Todd Zion Founder of Akston Biosciences Backed byPropel(X)Swati Chaturvedi SourcesAkston Biosciences' AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility — 2025-04 Browse all founders · Browse investors
